anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Callout

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 96,741
Current window 78,391-78,420
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all
18 30 60

Component

78,391-78,420 of 96,741

filter-aware
07
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
08
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
10
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
13
The slide uses the 'Outsiders' framework to establish a benchmark for Valeant's management philosophy.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor Loop · Tale Two Worlds1 hit
14
The slide uses a classic 'authority-citation' framework to validate the CEO's management style by aligning it with the principles of successful 'Outsider' CEOs.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor Loop · Tale Two Worlds1 hit
18
Slide 18 of 110 from an SEC filing.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
22
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
23
The chart uses a bridge-like structure to reclassify 85% of revenue as 'durable' by excluding the 15% 'Patent Cliff Rx' portion.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
24
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
25
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
26
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
28
The slide highlights the composition of Valeant's business segments and justifies their attractiveness.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
31
The slide highlights that the durable business represents ~85% of total sales.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
33
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
37
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
39
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
40
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
41
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
44
The slide uses a direct quote to frame the company's internal culture as a strategic choice.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
45
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
49
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
51
The table highlights the performance of 'Total Product Sales' across different periods.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
53
The slide contains a primary quote block and a footnote reference.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
54
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
56
The slide uses the 3G Capital case study as a precedent to validate Valeant's management philosophy.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
58
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
60
The slide uses a visual bracket to emphasize the cumulative difference between the two metrics over the three-year period.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
61
The slide highlights specific accounting adjustments used by Valeant to inflate earnings metrics.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
62
The slide uses a bridge-style reconciliation table to justify non-GAAP metrics.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
65
The slide uses a dual-axis chart to correlate share price (line) with volume (bars) and Pershing Square's specific purchase activity (dark bars).Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor Loop · Cost Of Inaction1 hit